Table 3. Gametocytemia and mosquito infection among infectious patients.

Treatment Arm	Subject ID	Day of followup	Gametocytes/μL	Pfs25 RT-PCR result	Mosquitoes infected	Oocysts/mosquito, median (range)
DHP + PQ	SN-060	0	728	+	35/50 (70%)	42 (1–231)
		2	670
		3	772		35/50 (70%)	21(1–56)
		7	71	+	0/50
		14	0	-	0/50
DHP only	SN-002	0	705	+	13/50 (26%)	1 (1–12)
		2	569
		3	427		22/50 (44%)	59 (1–147)
		7	247	+	37/50 (74%)	33 (1–120)
		14	161	+	6/50 (12%)	5 (1–15)
	SN-010	0	16	+	0/50
		2	87
		3	71		22/50 (44%)	3 (1–8)
		7	70	+	0/50
		14	0	-	0/50
	SN-063 (M*)	0	690	+	26/30 (87%)
		2	652
		3	860		26/30 (87%)
		7	844	+	27/30 (90%)
		14	250	+	19/30 (63%)
	SN-070	0	0	+	4/50 (8%)	1 (1–2)
		2	0
		3	0		0/50
		7	0	-	0/50
		14	0	-	0/50
	SN-086	0	0	+	?**
		2	47
		3	77		32/50 (64%)	6 (1–34)
		7	55	+	33/50 (66%)	9 (1–27)
		14	54	+	40/50 (80%)	12 (1–42)
	SN-108	0	342	+	49/50 (98%)	149 (48–398)
		2	412
		3	375		49/50 (98%)	78 (7–191)
		7	293	+	50/50 (100%)	111(32–147)
		14	80	+	49/50 (98%)	58 (14–132)
	SN-119 (M*)	0	118	+	3/30 (10%)
		2	145
		3	96		0/30
		7	42	+	0/30
		14	28	-	0/30

*Note that for subjects with mixed Pf/Pv infection(M), the percentage of infected mosquitoes was determined by species-specific PCR of individual mosquitoes, and oocyst counts are not reported because of inability to distinguish falciparum vs. vivax oocysts [18].

** Two of 5 and 5 of 5 pools of mosquitoes were real-time PCR positive at days 9 and 16 after feeding, respectively, but oocysts were not seen.